Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:36 pm Sale | 2023-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX | Flagship Ventures Fund V, L.P. | 0 0.000% | -797,721 (Position Closed) | Filing History |
| 2023-08-14 4:30 pm Purchase | 2023-08-11 | 13D | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 100 100.000% | 100 (New Position) | Filing History |
| 2023-07-07 4:33 pm Purchase | 2023-06-28 | 13D | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 1,008,830 40.300% | 797,719 (+377.87%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Sigilon Therapeutics, Inc. SGTX | BlackRock Inc. BLK | 82,007 3.300% | -51,574 (-38.61%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX | BlackRock Inc. BLK | 133,581 5.400% | 133,581 (New Position) | Filing History |
| 2021-02-16 5:06 pm Purchase | 2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX | Flagship Ventures Fund V, L.P. | 797,721 33.200% | 797,721 (New Position) | Filing History |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 211,111 8.800% | 211,111 (New Position) | Filing History |